FDA Inspection 1275741 — Avent, Inc.

Avent, Inc. — FEI 3006646024

The FDA completed an inspection of Avent, Inc. on July 10, 2025 in Tucson, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 10, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Tucson, AZ (United States)